Financials, Communication Sep 07, 2021 10:18 AM (GMT+8)
On September 6, Shanghai stansay Biotechnology Co., Ltd. announced that it had completed a round C financing of more than US $40 million. This round of financing was led by CDH VGC (CDH innovation and Growth Fund), and followed by a number of investment institutions. This round of financing will be used for the R & D of innovative couplecar platform technology, promote the development of cell therapy products for colorectal cancer and other solid tumors, and accelerate the process of clinical trials in the United States and China.
This text is a result of machine translation.